Directed-evolution approach to empower EGFR targeting for immunotherapy

Simple item page
dc.contributor.authorBunyarit Meksiriporn
dc.contributor.authorJamie B. Spangler
dc.date.accessioned2026-05-08T19:20:27Z
dc.date.issued2024-4-1
dc.description.abstractAdvances in directed-evolution technologies are enabling new strategies to isolate binding proteins that recognize disease-associated states of a target protein. In this issue of Cell Reports Methods, Dobersberger et al. devised a yeast display-based selection scheme to discover proteins that engage the cancer-associated activated state of a receptor to enable design of safe and effective immunotherapies.
dc.identifier.doi10.1016/j.crmeth.2024.100762
dc.identifier.urihttps://dspace.kmitl.ac.th/handle/123456789/17526
dc.publisherCell Reports Methods
dc.subjectCAR-T cell therapy research
dc.subjectViral Infectious Diseases and Gene Expression in Insects
dc.subjectMonoclonal and Polyclonal Antibodies Research
dc.titleDirected-evolution approach to empower EGFR targeting for immunotherapy
dc.typeArticle

Files

Collections

All